Equasym® Depot
Producer: Shire Sweden
contains
Equasym® Depot is a remedy for disturbance of attention, activity and impulsivity (ADHD).Active substances
methylphenidate
Application
Equasym® Depot is used for the treatment of disorder, activity and impulse (ADHD) disorder.
Equasym® Depot should only be used when treatment is initiated by a physician with particular knowledge of the treatment of ADHD.
Dosage
Available as modified release capsules. Children over 6 years and young people
- General initial dose of methylphenidate. Most often 5 mg (as tablets) 1-2 times a day. Alternatively, 10 mg (as modified release capsules) or 18 mg (as prolonged-release tablets) once a day in the morning.
- The dose is increased by up to 18 mg per week.
- Normalmaintenance dose 0.5-1.0 mg / kg body weight / day. The dose should not exceed 2.1 mg / kg body weight / day (or a total of 90 mg per day).
Adults
- General initial dose of methylphenidate: Most often 5 mg (as tablets) 2-3 times a day or 10-20 mg (as modified release capsules) once a day.
- The dose is increased by 10-20 mg weekly.
- maintenance dose. Great individual variation. The optimal dose depends on the individual's sensitivity to the substance. It is therefore necessary to increase the dose individually. Maintenance dose will in most experience be 30-150 mg per day. In rare cases higher doses may be required.
- There will often be a need for the dosage to ensure effect throughout the monitoring period.
Note:
- Experience is missing for older than 60 years and children under 6 years.
- To avoid sleep disturbances, capsules should be taken appropriately early in the morning.
- The capsules can be swallowed whole.
- The capsules may be open. Spread the contents on 1 tablespoonful yogurt or apple sauce immediately before ingestion.
- Capsules and capsule contents mustdoes not chewed or crushed.
possible side effects
Very common (over 10%) | Reduced appetite Nausea, dry mouth cold Symptoms Headache, Nervousness, Insomnia |
Common (1-10%) | Fever, feeling cold, for example on arms and legs, fatigue, thirst, weight loss Diarrhea, Indigestion, Abdominal pain, Vomiting, Dental pain Hypertension, heart rate, heart rate disturbances, cough, fast heart rate, upper respiratory tract, altered heart rate, changes in blood pressure, shortness of breath Growth retardation Joint pain Behavioral Disorder, Aggressiveness, Anxiety, Depression, Emotional Stability, Hyperactivity, Irritability, Restlessness, Asthma, Dizziness, Sleep Disorders, Sleepiness, involuntary Moving, Unrest and Restlessness Skin rash, skin rash, hair loss, hives, increased sweating Reduced sex drive |
Uncommon (0.1-1%) | Hallucinations, mood swings, motor disorder, psychosis, suicidal thoughts, drowsiness Allergic reactions (anaphylactic shock) Blood in the urine Double vision, Blurred vision |
Rare (0.01-0.1%) | angina Development of breasts in men Confusion, Way Blush Vision disturbance, blurred vision |
Very rare (less than 0.01%) | Hepatic effects Inflammation or clogging of the brain's vessel, blood clot in the heart, cardiac arrest, white fingers and toes due to contraction of blood vessels, sudden cardiac death Blood deficiency, bleeding in the skin and mucous membranes, increased risk of infection due to lack of white blood cells, increased tendency to bleeding due to decrease in platelets Cramps, malignant neuroleptic syndrome - severe condition with eg fever and awareness *, excessive repetition of movement or speech, overfocusing - difficulty in changing attention, suicidal behavior, thought disorder, involuntary movement disorders Severe skin reaction |
Unknown | Dependence of the agent, High fever Extra heartbeat, cerebral hemorrhage / blood clot in the brain, slow pulse Blood deficiency and increased risk of infection due to lack of white blood cells Migraine More frequent and persistent erection, Prolonged painful erection **, Travel problems |
* Mainly seen by concomitant treatment with other agents.
** Most commonly seen in dose changes.
- Nervousness and insomnia often occur at the start of treatment.
- Abdominal pain, nausea and vomiting usually occur at the start of treatment and may be reduced by taking the medicine with food.
- Growth inhibition can be seen as a common side effect of prolonged use in children.
- A number of side effects are only seen in adults (inflammation of the stomach mucosa, decreased sex drive, motor disorder, toothache and thirst) or seen with higher frequency in adults (decreased appetite, sleep disturbances, shaking, peripheral cold sensation, shortness of breath, nausea, dry mouth sweating and fatigue).
- The drug may cause embarrassment (euphoria) and may give rise to abuse and addiction. This is seen most frequently when using tablets that release methylphenidate rapidly in the body.
- At increases in dose - especially if done without the doctor's instructions - there may be a risk of developing psychoses with confusion, anxiety and paranoid reactions.
Should not be used
Should not be used
- by mania
- by psychoses
- by current or former severe depression
- If you suffer or have a history of certain types of manic episode disease
- by suicidal ideation
- by nervous eating (anorexia nervosa)
- if you suffer from cardiovascular disease or have had a cerebral hemorrhage or blood clot
- If you have increased metabolism
- by tumor in the adrenal gland (pharyochromocytoma)
- at elevated pressure in the eye (green throat).
Pregnancy
Can be used if necessary.breastfeeding
Can be used if necessary. This text differs from the company's approved product information (product summary).Traffic
Caution is advised in driving and machine operation.Blood donor
Do not drop. 4 weeks quarantine after end of treatment.doping
The use of Equasym® Depot results in exclusion from sports matches.effect
Works by increasing the amount of certain signal substances in the brain, includingdopamine. The half life in the blood (T?) is 2-3 hours.
Pharmaceutical forms
Capsules with modified release. 1 capsule contains 10 mg, 20 mg or 30 mg methylphenidate hydrochloride.
Special warnings
- The drug should be used with caution if:
- You have an increased risk of blood clots in the brain or brain bleeding
- you have or have had a cardiovascular disease or if some of your immediate family suffer from cardiovascular disease
- You have previously had convulsions
- You have an abuse of alcohol and / or medicine
- one suffers from involuntary muscular movements (motor tics)
- yourself or some in one's closest family have Tourette's disease (a neurological disorder with involuntary traits and the outburst of sounds).
- If you experience anxiety, agitation, aggression, suicidal thoughts or symptoms of psychosis or mania, consult your doctor.
- It is recommended that you check the blood pressure and pulse before and during treatment and be checked for symptoms of mental disorders. In some cases it may be necessary to take blood samples or take etecg.
- If you experience cardiovascular symptoms (eg palpitation, shortness of breath, chest pain triggered by exercise) during treatment, consult a doctor.
- In children, treatment should be evaluated every six months. One possibly. Pause in treatment should only be planned after careful consideration as the risk of relapse is increased. When treating adults, the advantages and disadvantages should be carefully considered before any break.
- In the treatment of children, height and weight should be checked at least every 6 months.
- In adults, the weight should be checked regularly.
- The drug may only be used for sleep apnea (short periods of breathing breaks during sleep) if the patient is already being treated for sleep apnea.
- Simultaneous intake of alcohol can enhance the mental and neurological side effects.
Using other medicines
It is important to inform your doctor about all the medicines you are taking.
- Equasym® Depot must not be taken if you have been in treatment with MAO inhibitors (agents for depression or Parkinson's disease) within the last 14 days.
- Drugs that stimulate blood pressure (pressurized substances) together with Equasym® Depot may cause high blood pressure.
- The effect of antihypertensive drugs may be reduced.
- Equasym® Depot may alter the effects of certain blood thinning agents, certain anti-convulsive agents, and certain anti-depression agents.
Grants, delivery, packages and prices
subsidies | extradition | Dispensing form and strength | Packing | Price in kr. |
Indicates that the medicine is subject to the rules in the Order on Prescriptions, §4. May only be delivered once after the same prescription, cf. section 14 | modified release capsules10 mg | 30 pcs. (Blister) | 326,95 | |
Indicates that the medicine is subject to the rules in the Order on Prescriptions, §4. May only be delivered once after the same prescription, cf. section 14 | modified release capsules20 mg | 30 pcs. (Blister) | 465,40 | |
Indicates that the medicine is subject to the rules in the Order on Prescriptions, §4. May only be delivered once after the same prescription, cf. section 14 | modified release capsules20 mgOrifarm | 30 pcs. (Blister) | 443,60 | |
Indicates that the medicine is subject to the rules in the Order on Prescriptions, §4. May only be delivered once after the same prescription, cf. section 14 | modified release capsules20 mg2care4 | 30 pcs. (Blister) | 428,00 | |
Indicates that the medicine is subject to the rules in the Order on Prescriptions, §4. May only be delivered once after the same prescription, cf. section 14 | modified release capsules 30 mg | 30 pcs. (Blister) | 627,40 | |
Indicates that the medicine is subject to the rules in the Order on Prescriptions, §4. May only be delivered once after the same prescription, cf. section 14 | modified release capsules 30 mgOrifarm | 30 pcs. (Blister) | 629,00 | |
Indicates that the medicine is subject to the rules in the Order on Prescriptions, §4. May only be delivered once after the same prescription, cf. section 14 | modified release capsules30 mg2care4 | 30 pcs. (Blister) | 465,00 | |
Indicates that the medicine is subject to the rules in the Order on Prescriptions, §4. May only be delivered once after the same prescription, cf. section 14 | modified release capsules 30 mgParanova Denmark | 30 pcs. (Blister) | 480,15 |
dyes
Indigotine (indigocarmin) (E132)
Iron oxides and iron hydroxides (E172)
Titanium dioxide (E171)
substitution
20 mg modified release capsules |
Equasym RetardParall Import Methylphenidate |
30 mg modified release capsules |
Equasym RetardParall Import Methylphenidate |